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Abstract
People with intellectual disabilities (PWIDs) are now living 
longer; thus, the incidence of cancer within this population 
is increasing. Available data indicate an excess of digestive 
tract cancers in PWIDs, but colorectal cancer has rarely been 
specifically studied and has not been extensively reviewed. 
This is despite risk factors such as being overweight, obesity, 
and lack of exercise being more frequent in PWIDs. In this 
article, we examine the literature on the frequency, screen-
ing, and treatment of colorectal cancer in PWIDs by as- 
sessing 4 databases, Medline, EBSCO-CINHL, ASSIA, and 
PsychLIT, from 1970 to February 2017. Findings indicate that 
the frequency trends slightly higher than that found in the 
general population. Screening presents a unique opportu-
nity to discover early colorectal cancer, but is underused in 
PWIDs compared to the general population. Furthermore, 
the clinical presentation is frequently masked, particularly 
by challenging behaviours, and colorectal cancer is there-
fore often diagnosed late, making treatment difficult due to 
the advanced stage of these tumours. To improve the care 
of PWIDs, we need more resources to support them and their 
caregivers, and to increase awareness of the risk factors and 
signs and symptoms of colorectal cancer.
© 2018 S. Karger AG, Basel
Introduction
People with intellectual disabilities (PWIDs) are living 
longer and, as with the wider population, increasingly ex-
periencing serious illnesses such as cardiovascular and re-
spiratory diseases [1]. However, cancer is an age-related 
disease and has not received the same attention as other 
medical problems in this population [2, 3]. Evidence on 
overall cancer incidence in PWIDs is limited due to the 
lack of reliable epidemiological data [4] but is currently 
estimated to be as frequent as in the general population 
[5, 6]. On the other hand, the pattern of cancer in PWIDs 
differs from that of the general population and suggests a 
higher risk for gastrointestinal cancers [5, 7, 8]. Colorec-
tal cancer is 1 of the 4 most common cancers in the world 
[9]. It accounts for nearly 10% of the global incidence of 
cancer worldwide and constitutes the third most com-
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mon cancer in men and the second most common in 
women [10], but its risk in PWIDs remains relatively un-
known.
Recognized risk factors for colorectal cancer are being 
overweight and lack of physical activity, as well as con-
sumption of red meat, processed meats, and alcoholic 
beverages [10]. PWIDs are more prone to being over-
weight with the prevalence of overweight and obesity es-
timated at around 30% [11, 12]. Being overweight is an 
important risk factor for colorectal cancer, with an esti-
mated increased risk of 41% for a body mass index (BMI) 
> 30 compared to a BMI < 23 [13]. Additionally, PWIDs 
are less involved in physical activity; a recent Australian 
study indicated that 60.3% of 68 adult PWIDs did not 
reach the national physical activity guidelines [14]. Glob-
ally, PWIDs are low consumers of alcohol compared to 
the general population. However, they have a moderate 
risk of malnutrition, with 17.6% of them in the high-risk 
category [14]. Constipation, which is clearly more preva-
lent in children and adults with IDs [15], is currently not 
considered a risk factor for colon cancer. Globally, being 
overweight, obese, inactive, or having poor nutrition, are 
well-documented factors which increase the risk for 
colorectal cancer within PWIDs. These characteristics 
suggest a potential increased risk for colorectal cancer 
which might be prevented by modifying and reducing 
obesity and increasing physical exercise. However more 
research is needed to clarify these findings [12, 16].
When discovered early, particularly by screening [17], 
colorectal cancer has a lower mortality rate than many 
cancers. However, cancers in PWIDs are often discovered 
late [18]. Screening for colorectal cancer uses either a fae-
cal occult blood test (FOBT) or, more recently, a faecal 
immunology test (FIT), both of which look for blood in 
the faeces, while colonoscopy or sigmoidoscopy allows a 
direct visualization of the colon. Colorectal cancer screen-
ing is only a recent national imperative: for example, be-
ginning in France in 2009 and in the UK in 2010. In the 
UK, screening begins at 50 years of age in Scotland or 60 
years of age in England, Wales, and Northern Ireland, 
with the FOBT/FIT test being done every 2 years until 74 
years of age. In France the screening begins at 50 years 
until 74 years of age. To date, few data are available to as-
sess the impact of such screening programmes.
Colonoscopy is the major method to confirm diagno-
sis and collect tumour samples in cases where colorectal 
cancer is suspected. The procedure allows a visual evalu-
ation of the entire colon and rectum and permits the bi-
opsy of anomalies. In some countries, and in particular 
the USA, colonoscopy is a first-line screening method, 
whereas in other countries, such as the UK and France, 
the primary test is an FOBT in the global population with-
out familial history of colorectal cancer or adenomas. If 
blood is detected, a second FOBT may be required, and 
colonoscopy undertaken if the FOBT is positive. Once a 
diagnosis is made, colonoscopy is needed for detecting 
and removing lesions and to confirm the diagnosis. This 
entails administering a preparation, consisting of various 
agents: stimulants, enemas, osmotic agents, and polyeth-
ylene glycol-based solutions to clean the lower digestive 
tract. Furthermore, an individual must be able to con-
sume at least 4 L of clear liquid. The quality of the colo-
noscopy is directly related to the quality of the prepara-
tion of the colon [19]. This article aims to review the lit-
erature on colorectal cancer to explore the evidence to 
inform health and social care practice. 
Methods
An integrative review process was chosen, as they offer oppor-
tunities to critique and synthesise literature from a diverse range 
of primary research to enable the current state of knowledge to be 
examined, especially when there is limited literature [20–22]. The 
aim of the literature review was to explore the literature on colorec-
tal cancer and bowel screening in PWID.
The review of the literature was not restricted by date and in-
corporated literature from 1970 to 2017. Careful consideration was 
given to search terms, especially as there is no universally accepted 
term to describe PWIDs. Consequently, intellectual disability in all 
its forms was used (see Table 1), alongside colorectal neoplasms or 
bowel cancer or bowel neoplasm or colon cancer or colorectal can-
cer, as these terms embraced the nomenclature for colorectal can-
cer. Screening was also added to the search terms since bowel 
screening was in place in some countries. Four databases (Medline, 
ASSIA, EBSCO-CINHL, and PsychLIT) were used for this review 
as these incorporated medical databases related to PWIDs [21, 22]. 
The terms were used in combination and were adjusted to suit the 
terminology of the database searched. To capture the “grey litera-
ture,” and ensure total coverage of the data, searches of profes-
sional organizations (e.g., Foundation for People with Learning 
Disabilities), government bodies (e.g., Learning Disabilities Ob-
servatory, England), and special interest groups were performed 
Table 1. Main terms to identify material on learning disability
Intellectual disability(ies)
Developmental disability(ies)
Mental retardation 
Learning disability(ies)
Mongolism/mongoloid
Learning difficulty(ies) 
Mental handicap
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[23]. Hand searches were also undertaken by reviewing the refer-
ence lists of the articles retrieved by the database searches. It should 
be noted that due to the limited literature available all types of 
studies and interventions were considered [22]. In addition, rather 
than review the empirical literature, the authors wanted to update 
current knowledge on colon cancer and bowel screening; hence, 
articles were included that had an educational slant as well as in-
formation booklets aimed at supporting the PWID and the care-
giver. The number of articles retrieved by each database and search 
term is shown in Figure 1.
The inclusion criteria consisted of all studies being written in 
English and relating specifically to colon/bowel screening/cancer 
screening in PWID. It should be noted that 2 articles, 1 French and 
1 Japanese, were included due to their relevance and availability of 
translations. Exclusion criteria extended to other cancers/cancer 
screening. Titles and abstracts were screened to ensure adherence 
to the inclusion criteria and eligibility to the final literature review. 
In total, this review contains 55 pieces of literature: 49 articles and 
6 information booklets are reported. Table 2 indicates the main 
studies with the exception of case studies and information book-
lets, to avoid repetition of data extraction. The CASP [24] and 
Whittemore and Knafl [22] were drawn on for the data extraction 
criteria for Table 2; whilst the Joanna Briggs Institute Levels of 
Evidence [25] were used for quality appraisal, where 1 was the 
highest and 5 the lowest. The articles found relate to 4 areas: pop-
ulation and mortality studies, institutional population, genetic 
conditions, and clinical presentation and treatment in PWID. The 
focus of the review is on colon cancer and screening and treatment 
to raise the awareness of colorectal cancer in health of social care 
practitioners.
Results
Population and Mortality Studies
There are a number of studies exploring cancer in this 
population, which are divided into epidemiological stud-
ies and those of PWIDs living in institutions, with their 
family, or in the community. Two epidemiological and 2 
mortality studies are available. The first, conducted in 
Finland on 2,173 PWIDs (1,090 men and 1,083 women) 
between 1967 and 1997, was a data linkage study, linking 
a register of PWIDs (which determined their level of ID) 
to a cancer registry. These individuals were then followed 
up. Findings for sex were not reported separately but a 
standardized incidence ratio (SIR) of 0.9 for colon and 
Medline, EBSCO–CINHL, and PsychLIT 
Term 1
Colorectal neoplasms or
“bowel cancer*” or “bowel
neoplasm*” or “colon
cancer*” or “colorectal
cancer*”= 157,024    
Term 2 
Intellectual disability or learning
disabilit* or learning difficult* or
“developmental disabilit*” or “intellectual
disabilit*” or “mental retard*” or “mental
handicap*” or mongolism or mongoloid
= 114,857    
Terms 1 and 2 combined = 42 
Term 3
Mass screening or
screen* = 564,922 
Terms 1, 2 and 3 combined = 9 
11 articles removed due to not fitting 
inclusion criteria or were not relevant
Hand searches and grey
literature: 17 
Total: 55 pieces of literature
49 articles
6 information booklets  
66 articles screened for title and abstract 
Fig. 1. The number of papers relating to PWIDs and colon screening and colon cancer.
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rectal cancer in both sexes was reported and internation-
al classifications of disease were used as the diagnostic 
criteria. Eight patients with colon cancer were observed 
while 9.3 were expected (SIR 95% CI 0.4–1.7), and 6 pa-
tients with rectal cancers were observed while 7 were ex-
pected (SIR 95% CI 0.3–1.9) [5]. The second study, con-
ducted in Western Australia on 9,409 PWIDs between 
1982 and 2001, was another data linkage study, linking an 
intellectual disability database to a cancer registry. There 
were 14 male patients with colon or rectal cancers when 
9.38 were expected, indicating an increased SIR of 1.39 
(95% CI 0.14–2.37). Nine cases were observed for women 
when 2.9 were expected, indicating an increased SIR of 
3.10 (95% CI 1.42–5.88) [6]. Both authors noted the small 
sample size as a limitation.
A mortality study conducted in the UK reviewed re-
cords from the Leicestershire Intellectual Disability Da-
tabase between 1993 and 2006. It included patients with 
moderate to profound intellectual disabilities living 
mainly in institutions but also with their family or in-
dependently in the community [26]. From 2,995 adults, 
there were 47 cancer deaths, giving a standardized mor-
tality ratio (SMR) for all cancers of 0.94. Of these, 4 were 
colorectal cancers. Another UK-based study examined 
cancer mortality records for PWIDs between April 
2010 and March 2014 [8]. Of the 664 deaths (371 male, 
293 female) 13% (n = 87) of mortalities were cancer re-
lated, with cancer of the digestive tract being the largest 
subgroup identified (32 of the 87 observed deaths). Six-
teen of these deaths were related to colon and rectal 
cancer, while 6.8 were expected (SMR for men 2.68, 
SMR for women 1.85). However, the authors noted that 
recognition thresholds vary between countries and re-
gions.
The final study reviewed mortality in PWIDs aged 18 
years and older among service users of the Massachusetts 
Department of Developmental Services (DDS) over a 
2-year period (2012–2013) [27]. The findings revealed 
that cancer was the second leading cause of death, result-
ing in 13.4–13.7% of deaths each year. Colon cancer was 
one of the main causes of cancer deaths (n = 18/847). This 
study, however, focused on those registered with services 
and may have missed those who have no contact with ser-
vices. Although the above studies are seen as offering a 
high-quality evidence base, there are some caveats. Data 
linkage work is not able to offer total coverage of the pop-
ulation as there will always be missing or incorrect data. 
Not all data were reported by incidence by age whilst 
none of the studies were total population studies for the 
respective countries.
Institutional Population
More data are available for PWIDs living in institu-
tions than for the general population of PWIDs. Data 
from 3 consecutive British studies by the Stoke Park 
group of hospitals used cause of death of their residents 
as documented in hospital records over a 65-year period 
(1930–1995). However, it should be noted that these 
studies did not use the international classification of dis-
eases, did not report incidence by age, and standardised 
mortality measures were not employed. Results suggested 
an increased frequency of colon and rectal cancer in 
PWIDs compared to the general population. Among 61 
PWIDs who died from cancer during the 40-year period 
from 1936 to 1975, 10 (12%) succumbed to colon (n = 5; 
1 male, 4 female) and rectal (n = 5; 4 male, 1 female) ma-
lignancies. The authors emphasized that, compared to the 
general population, relatively more PWIDs die from 
these cancers (17 vs. 13%) [7]. Between 1976 and 1985, 53 
PWIDs died from cancer, 31 of them (58.5%) from cancer 
of the gastrointestinal tract (4 women died of colon can-
cer) [28]. Finally, from 1986 to 1995, of 213 deaths, 7 of 
the 27 cancer deaths (25.9%) were related to tumours lo-
cated in the colon (n = 4) or in the rectum (n = 3) [29]. 
Another study from the group estimated serum choles-
terol levels from 496 PWIDs (258 female, 238 male). They 
found 23 colon cancers (12 male, 11 female) and that their 
serum cholesterol levels were significantly lower than 
those who died from other causes [30]. No other study 
has looked at this or found similar associations. The Stoke 
Park studies are useful, but have limitations; for example, 
the diagnostic criteria were not explicit and standardised 
mortality measures were not employed. An Israeli study 
reviewed 450 records of death in 53 residential centres 
between 1991 and 2005. The findings revealed 74 cancer 
deaths from people with mild, moderate, or severe IDs 
living in institutions. Colorectal cancers accounted for 
9.4% of these cancer deaths [31]. A limitation was that 
those who died at home or in a foster family were not in-
cluded in this study. A recent study in France used data 
from a large survey of 1,519 institutions, finding 3 cases 
of colorectal cancer among a total of 32 cancers, while 1 
colorectal cancer was expected, suggesting a non-signifi-
cant increase with an associated SIR of 3 (95% CI 0.6–
8.76) [32]. 
A Japanese study found PWIDs not to be at more risk 
of adenomatous polyposis syndrome (APS) or colon can-
cer [33]. Colonoscopy screening was undertaken in an 
institution of 134 patients (age range 32–69 years). Al-
though polyps were found in 24 patients (17.9%), and ab-
normal fixation, haemorrhoids or melanosis coli in 2 pa-
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tients (1.5%), respectively, there were no cases of APS or 
colon cancer detected. In a review of the literature [34], a 
higher frequency of colon cancer in PWIDs living in in-
stitutions was observed compared to those who lived with 
their family or in the community. The authors indicated 
that patients with moderate to severe IDs tend to live in 
institutions and are more prone to colorectal cancer than 
patients with mild IDs, who often live in the community. 
However, the data presented in this review did not pro-
vide a precise answer on the degree of cancer risk accord-
ing to the level of ID and were insufficient to evaluate dif-
ferences between women and men. It should be noted 
that no particular histological type was described for the 
colon cancers reported in PWIDs within these studies, 
which is significant in order to determine the stage and 
type of cancers identified.
Genetic Conditions
There are particular genetic conditions which carry in-
creased risk factors for these malignancies. Patients with 
sub-microscopic or a larger 5q deletion, which includes 
the APC gene, show features of familial adenomatous pol-
yposis (FAP) syndrome. This is defined by the occurrence 
of more than 100 colon polyps and has a very high risk of 
colon cancer occurring earlier than in the general popula-
tion. Some FAP patients also present mild intellectual dis-
ability and slight dysmorphism, and 7 such patients (2 
male, 5 female) have been reported in the literature as case 
studies. As expected, some developed a carcinoma before 
the age of 50 years [35–39] or presented polyps with high-
grade dysplasia, a clear indicator of a pre-neoplastic le-
sion [35, 40]. Other case studies have revealed at least 3 
patients (2 male, 1 female) with a small deletion of a chro-
mosome harbouring genes implicated in hereditary non-
polyposis colorectal cancer (2p, 3p, 7p) who also had IDs 
and developed colon cancer, 2 of them early in life [41–
43]. For example, a male patient with a mutation in the 
PMS2 gene was diagnosed with a rectal carcinoma aged 
14 years [44], whilst a man with mild to moderate ID due 
to Williams syndrome and Lynch syndrome (which in-
creases the risk for colon neoplasia) developed a colorec-
tal cancer aged 37 years [45]. In a Danish cohort of 597 
women with Turner syndrome, those who presented with 
mild IDs were found to be at a higher risk of colon cancer 
compared to women in the general population [46]. The 
authors suggested that there was almost complete follow-
up. Two colorectal carcinoma cases have been reported in 
a neonate and a young adult with trisomy 13 [47], and 
such tumours were described in a female patient with tu-
berous sclerosis [48]. A literature review on individuals 
with Down syndrome and digestive cancer identified 39 
colon cancers, but overall people with Down syndrome 
develop fewer digestive neoplasms compared to PWIDs 
[49]. In a Finnish data linkage study from a cancer regis-
try of PWIDs (1982–1986), 302 people with fragile-X syn-
drome were followed-up on cancer incidence until 2005 
[50]. The findings were unclear as, although 11 cancers 
were reported, only 1 cancer was coded as digestive and 
another was unspecified, hence it was unclear whether 
these were related to colon cancer. Either way, the last 2 
studies identified that colorectal cancers appear rarer 
compared to the general population and the occurrence 
remains less well established [49–50].
The evidence here is mainly reliant on case studies, 
which are not themselves representative of the popula-
tion. Despite this, they sensitise researchers towards some 
of the risks within this population. 
Screening
Given that screening is a relatively recent development, 
there is a dearth of research. A survey of general practitio-
ners in the UK revealed a very low participation rate of 
5.92% among 6,566 PWIDs and produced an adjusted in-
cidence rate ratio of 0.86 compared to the incidence in 
non-disabled adults. However, the study was conducted 
shortly after the commencement of screening, and the 
participation rate in the general population was also found 
to be low [51]. More recently, work in the UK collecting 
data through the Joint Health and Social Care Self-Assess-
ment Framework (JHSCSAF), a mechanism within Public 
Health England of collecting data on PWIDs in England, 
suggested that, of all screening programmes in the UK, 
colorectal screening had the highest uptake in PWIDs, 
with an uptake of 41.6% in PWIDs, lower than the 50.4% 
uptake in the general population [52]. This is in contrast 
with other work in the UK published a year earlier and 
again obtained from the JHSCSAF, which suggested lower 
rates for bowel screening in PWIDs (28.1%) compared to 
the general population (40.5%) [53]. Canadian work com-
paring 15,791 PWIDs and 791,792 without IDs from ad-
ministrative health and social services datasets for Ontar-
io residents aged between 50 and 64 years has suggested 
lower colorectal cancer screening rates for PWIDs (32%) 
than in the general population. Of those PWIDs, 18.5% 
had undergone a FOBT compared to 26.4% of the non-
disabled population between 2008 and 2009 [54]. It must 
again be remembered that the population in these studies 
only reflects those in contact with services or appearing on 
social service records. In one study [54] the authors ac-
knowledged the limited availability and access to data.
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In France, a study of 653 PWIDs aged 50–74 years liv-
ing in institutions found that the participation rate was 
10% lower, with only 24% undergoing FOB testing com-
pared to 34% in the general population [32]. In the USA, 
a review of participation in proctoscopy/sigmoidoscopy/
colonoscopy and FOBT in 101,045 people with disabili-
ties from 1998 and 2000 found it was lower in individuals 
with various disabilities compared to the general popula-
tion [55]. The problem with this paper is that the types of 
disabilities were not documented separately and again 
full coverage may not have been attained. Another Amer-
ican study undertook a survey of hospital records be-
tween 2000 and 2009 and identified 7,778 PWIDs, 2,938 
blind/low vision patients, 7,126 spinal cord injury pa-
tients, and 35,036 without IDs from their billing records. 
These indicated that only 34% of adults with IDs (vs. 48% 
of adults without IDs) aged 50–75 years adhered to 
colorectal cancer screening over the 10-year period [56]. 
These results must be reported with caution, firstly be-
cause all other disabilities were included in those without 
IDs. Furthermore, hospital billing records are not an ac-
curate means of identifying compliance with screening 
due to administrative coding systems being subject to hu-
man error, and in this case ICD-9-CM codes for disabili-
ties were not recorded if different from the underlying 
condition, whilst some participants may have been 
screened prior to the study and coded as non-compliant. 
In Australia, surveys were distributed to 2,540 PWIDs 
and their immediate support persons [57]. Of those re-
turned, 51 were rejected due to incomplete data and 659 
were analysed, giving a 26% response rate. Participation 
in FOBT was 7.5% for PWIDs aged 18–76 years, but data 
for people aged 51–74 years was not reported. The find-
ings, however, have several weaknesses; for example, the 
non-responders may be a different population, surveys 
were only sent to those in contact with services, and there 
is always the possibility of recall bias or interpretation is-
sues of the questions posed.
Work in terms of facilitating bowel screening is lim-
ited and comes mainly from the UK. One study reviewed 
records from a local Direct Enhanced Service register and 
identified 238 clients aged 60–74 years who were eligible 
for FOB screening, of whom 19 (8%) had participated in 
the screening [58]. Information was collected from 31 of 
47 GP practices, with no indication of why all practices 
were not consulted. Another study reported within the 
paper used health promotional materials aimed at in-
creasing the uptake of FOB screening. Community nurs-
es within the region were asked to support 1 PWID to 
undertake the test and 12 further clients were supported 
with successful screening, with 1 test being positive. The 
studies were not clearly documented, making evaluation 
difficult. Another study increased uptake by 14% through 
the community learning disability team developing ac-
cessible screening letters, a training pack for PWIDs and 
carers, and a system to flag up non-responders [59]. Of 
the 239 people eligible for bowel screening, 36 declined to 
participate and 6 were too unwell. Bowel screening was 
discussed with 193, and 117 undertook the test (the re-
maining had either died, were ill, or had moved). Of 99 
participants undertaking the test no further action was 
required, whilst 18 others required colonoscopy follow-
up (no further results were reported). The team acknowl-
edged they may not have identified all PWIDs and the 
education pack may not have suited all needs.
Within the literature there were a number of educa-
tional papers aimed at improving awareness about bowel 
cancer and screening. The first identified professionals as 
being crucial to active participation in bowel screening, 
as they were best placed to educate and encourage PWIDs 
[60], whilst the second [61] aimed at improving access to 
5 screening services, 1 of which was bowel cancer. The 
team identified that there were no mechanisms to iden-
tify PWIDs, and advocated for PWIDs to be identified so 
that reasonable adjustments could be put in place. For 
example, they suggested that the GP practice should in-
tervene 13 weeks after failure to respond to an invitation 
to attend bowel screening. Follow-up tests for positive 
FOBs identified that standard invitation letters were is-
sued for a further screening appointment within 14 days. 
This meant there was limited time to enact reasonable 
adjustment. Another literature review on screening in 
PWIDs contained limited literature on cancer screening, 
although recommended following national guidelines for 
bowel screening [62].
Clinical Presentation and Treatment 
Reports indicate that symptoms in PWIDs are similar 
to those observed in individuals without IDs: rectal bleed-
ing [36, 43, 44, 48, 60, 62], diarrhoea [36, 48] and abdom-
inal pain [30, 39, 48, 63], with other tumours being dis-
covered early, resulting from investigations for anaemia 
[41]. One educational paper used 2 case studies to exem-
plify the difficulties that PWIDs can experience, such as 
the delay in reported rectal bleeding before medical inves-
tigations are undertaken [60]. Sometimes cancers are de-
tected late, as observed in a study exploring deaths 
through abdominal obstruction. Of the 32 patients ob-
served, 2 patients with mild to moderate IDs were diag-
nosed late from intestinal obstruction, and both died 
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from colorectal cancer [64], whilst another case study 
[63] found that 1 male patient with ID had died before a 
cancer diagnosis was made. The authors of this review 
found no systematic studies or evaluations unanimously 
indicating whether colorectal cancer was diagnosed late 
in PWIDs. 
The use of colonoscopy to confirm diagnosis has been 
found to be difficult to perform in PWIDs [43]. One study 
found that the preparation for colonoscopy was adequate 
for only 51% of 40 patients with profound, severe, moder-
ate, or mild IDs, compared to 97% of control patients 
without ID, whilst inadequate preparation meant that a 
caecal carcinoma was missed, and an advanced adenoma 
could not be removed [19]. This, however, was one study 
in one limited area and is not a reflection of all colonos-
copy units. The dearth of literature precludes the authors 
determining if poor preparation for colonoscopy is a 
worldwide issue for PWID. However, poor preparation 
can necessitate a second colonoscopy [40] or even gen-
eral anaesthesia [65]. There is limited research on how to 
prepare PWIDs for colonoscopy, other than the findings 
of the previous study and an educational paper about 
bowel cancer [66]. Suggestions were to make special ar-
rangements and reasonable adjustments [19] in conjunc-
tion with the use of guides to explain colonoscopy to 
PWIDs [66].
The literature on the treatment of cancer is limited and 
where there have been delays in diagnosis the cancer will 
be at a more advanced stage [36, 59, 67]. Even if caught 
early, the PWIDs and those who support them have to 
make informed decisions. Within the review, a number 
of booklets were identified about how to explain cancer 
screening, diagnosis, and treatment in simple terms to 
PWIDs from a number of countries. These include: Get-
ting on with Cancer [68], Living with Cancer 3: Colorectal 
(Bowel) Cancer [69] (Family Advice and Information Re-
source in Scotland, FAIR, no date; a CD was also avail-
able), Having a Colonoscopy [70], An Easy Guide to Hav-
ing a Colonoscopy (NHS Cancer Screening Programme, 
no date), and Keeping your Bowel Healthy [71] in the UK; 
Undersokelse og behandling av kreft (one for men one for 
women [72]) in Norway, and in France, Lucie est soignée 
pour un cancer, which has a scenario based on a woman 
with colon cancer (Fig. 2) [73]. It is not the purpose of this 
review to evaluate the value of these publications; how-
ever, the authors believed it important to identify their 
existence. It should also be remembered that studies look-
ing at cancer note the difficulties for treating this popula-
tion due to barriers to treatment and follow-up proce-
dures [61, 62, 74], and that patients may refuse treatment 
[62, 65]. This review only identified 1 British case study 
discussing aftercare, in this case dealing with stoma, in 
PWIDs [75]. The findings indicated that staff were poor-
ly educated in terms of supporting PWIDs with stoma 
care, and this lack of knowledge and training was also ap-
parent in home settings with the family and paid caregiv-
ers. These findings were reflected in another education 
article [76]. Due to the lack of evidence, it is unclear 
whether this reflects the situation worldwide given this 
work related to 1 individual. Similarly, there was 1 case 
study from Japan about chemotherapy which was suc-
cessfully delivered at home [67]. 
Discussion
Despite the limitations of identifying populations, 
mortality data, and institutionalized studies, the findings 
reported suggest that PWIDs have at least a similar risk 
of colorectal cancer as the general population [6, 8, 27–31, 
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Fig. 2. A picture from the booklet Lucie est soignée pour un cancer, 
showing surgery being performed on the patient.
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34]. There is a suggestion that a higher incidence may be 
associated with genetic deletions and family history, es-
pecially those with sub-microscopic or a larger 5q dele-
tion due to their higher propensity for FAP than in the 
general population [35–39], as well as other genetic dele-
tions which the research suggest harbour genes implicat-
ed in colorectal cancer [42–50]. Despite this, there re-
mains indication of a slightly lower risk [5]. Robust con-
clusions are difficult to make due to the studies not 
reporting the histology of the colon cancers reported in 
PWIDs, and without this it is impossible to determine the 
stage and type of cancers identified. There is a suggestion 
that women with IDs are at higher risk than men [6, 28, 
30], but there is a more mixed picture from the case stud-
ies. Interestingly, aside from the case studies, colon can-
cer was found in children with PWIDs [47, 49]. Overall, 
findings indicate vigilance about colorectal cancer is 
needed when assessing the health or changes in behaviour 
in PWIDs. The introduction of bowel screening and en-
couragement to undertake screening by health and social 
care professionals working with PWIDs should help this 
[60, 62, 63, 76]. More studies are important that report 
the histological type of colon cancer so that firmer con-
clusions can be drawn.
The picture that emerges from the limited range of 
studies regarding bowel screening is that the uptake of 
bowel cancer screening is lower for PWIDs and reflects 
the pattern of uptake in the other cancer screening pro-
grammes. This is concerning given the epidemiological 
data and institutional research reported above which sug-
gests a comparable risk of colon cancer as in the general 
population [6, 8, 27–31, 32, 34]. Unlike other cancer 
screening programmes, bowel screening it is less invasive 
and offers a unique way to detect cancer early in patients 
who have difficulties accessing health care. Despite this, 
there are recognized barriers to cancer screening for 
PWIDs: difficulties in obtaining informed consent, lack 
of accessible information, inadequate support to com-
plete the test, reduced accessibility to screening proce-
dures, and negative attitudes and limited awareness about 
PWIDs among health professionals [59, 77–81]. One of 
the biggest difficulties is that PWIDs often find it difficult 
to communicate their pain and unease, and often react 
with unusual and sometimes challenging behaviour [82], 
such as quietness or overactivity. Many caregivers, how-
ever, may not be aware of the cancer risk of adults with 
IDs, meaning significant symptoms may be neglected and 
consequently long delays can occur between the onset of 
symptoms and diagnosis [83]. For this reason, caregivers 
need to be vigilant about complaints and/or changes in 
behaviour, to avoid the diagnosis being made too late 
[84, 85].
Unfortunately, lack of early identification is often at-
tributed to poor knowledge about cancer and cancer 
screening in health and social care staff [58, 78, 81, 83]. 
For example, 1 study [81] surveyed 324 social care staff, 
reporting that 89% had received little training in cancer 
care, whilst 83% noted their knowledge of the signs, 
symptoms, and risks of cancer was limited. This was sup-
ported by previous work suggesting limited knowledge 
and training of health staff, including GPs, nurses, and 
radiographers [61, 62, 86–88]. As bowel cancer is seen as 
a condition that can be identified earlier, improvements 
at local and national levels are needed in order to provide 
information and follow-up of PWIDs [76, 78]. Work fa-
cilitating bowel screening is emerging mainly from the 
UK, and focuses on local projects to increase awareness 
and education about bowel screening and advocating 
greater contact with the learning (intellectual) disability 
care teams [52, 58, 59, 61]. The introduction of bowel 
screening has also seen a number of resources for caregiv-
ers and nurses who want to enable PWIDs to prepare for 
screening, a possibly difficult diagnosis, and the thera-
peutic journey.
If further investigation was required, the literature 
identified that preparation was difficult for those needing 
colonoscopies due to the nature of the agents and compli-
ance with the regime to clean the bowel. For this reason, 
many PWIDs were found to have poor-quality colonos-
copies, which increased the risk of cancers being missed 
[19, 43]. This is compounded by research identifying that 
oncology nurses and doctors often lack the necessary 
training to communicate effectively with PWIDs, and 
therefore do not meet the patient’s needs and rely on the 
caregivers [74, 89, 90]. These and other studies indicate 
the importance of increasing the training and knowledge 
of physicians and nurses to improve understanding and 
confidence in communication when working with PWIDs 
[86–90].
Research on treatment options for colon cancer in 
PWIDs was limited, but reiterated the barriers and lack of 
training in health and social care professionals. This is 
concerning as the wider literature has identified poorer 
results for abdominal surgery in people with cognitive 
impairment due to delayed diagnoses, operative technical 
errors, and increased risk of postoperative complications 
[64, 91, 92] and limited successes [41]. PWIDs have in-
creased risks from anaesthesia, there are known intuba-
tion risks in people with Down syndrome [93], and the 
choice of anaesthesia agents [94]. The wider literature 
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also identifies issues with outpatient treatment in that, if 
chemotherapy is offered, it may be difficult to provide to 
PWIDs as an outpatient [67] and will most certainly need 
to be adapted due to increased condition-specific side-
effects to some antineoplastic agents [95]. Issues also oc-
cur after discharge in terms of communication difficulties 
between the general practitioner, caregivers, and the on-
cological team [80]. Although colon and rectal cancer are 
treatable without major difficulties, it remains imperative 
to obtain an early diagnosis. For this to happen, greater 
uptake of bowel screening needs to be achieved, along 
with better awareness about the signs and symptoms of 
bowel cancer in health and social care staff and training 
for staff in the oncology units. 
Conclusion
As discussed above, literature reporting epidemiologic 
and mortality evidence on the incidence of bowel cancer 
in PWIDs is scant. Despite this, the available evidence 
suggests that colorectal cancer frequency in PWIDs is at 
least equivalent to that found in the general population. 
It is possible that incidence is masked by difficulties in 
diagnosis due to communication problems and the lim-
ited training of health and social care staff for identifying 
the signs and symptoms of this disease within this popu-
lation. This can lead to tumours being discovered late or 
not at all. If tumours are diagnosed at an advanced stage, 
treatment options are limited, and the associated aggres-
sive interventions may impair compliance. It is therefore 
important to consider preventative measures, such as 
bowel screening. PWIDs have a number of risk factors: a 
high incidence of obesity, limited access to exercise, and 
poorer dietary intake of fibre. Many of these risks could 
be reduced by caregivers being vigilant in terms of bowel 
habits and implementing interventions to increase fibre 
intake and exercise in daily activities. It is essential to in-
crease participation in screening, especially as it repre-
sents one of the least invasive options for care. For this to 
succeed, accessible information must be made available 
for both PWIDs and those who support them. This can 
only be achieved with greater investment and the devel-
opment of professional education for paid staff and fam-
ily members, as well as increased awareness of the needs 
of PWIDs within oncology teams.
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